cbdMD (YCBD) Cash & Equivalents Growth (1y) (2017 - 2026)
cbdMD (YCBD) Cash & Equivalents Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | -4.65% |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 99.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 99.93% |
| Dec 31, 2025 | 71.96% |
| Sep 30, 2025 | -7.80% |
| Jun 30, 2025 | -55.76% |
| Mar 31, 2025 | -16.16% |
| Dec 31, 2024 | 30.92% |
| Sep 30, 2024 | 36.42% |
| Jun 30, 2024 | -15.86% |
| Mar 31, 2024 | 22.51% |
| Dec 31, 2023 | -55.11% |
| Sep 30, 2023 | -73.25% |
| Jun 30, 2023 | -70.20% |
| Mar 31, 2023 | -87.11% |
| Dec 31, 2022 | -82.98% |
| Sep 30, 2022 | -74.56% |
| Jun 30, 2022 | -49.68% |
| Mar 31, 2022 | -43.75% |
| Dec 31, 2021 | -31.52% |
| Sep 30, 2021 | 78.16% |
| Jun 30, 2021 | 26.51% |